Sysmex XE-5000 Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe, Japan; Sysmex America, One Nelson C. White Parkway, Mundelein, IL 60060; catalog #063-7591-7 The Sysmex XE-5000 is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories. The XE-5000 performs analyses using the following methods: RF/DC Detection Method, Sheath Row DC Detection Method, and Flow Cytometry Methods using a Semiconductor Laser. Particle characterization and identification is based on detection of forward scatter, fluorescence and adaptive cluster analysis. Using the same reagents as the XE-2100, the XE-5000 automatically classifies cells from blood and body fluids and carries out all processes automatically from aspiration of the sample to outputting the results.
Published November 14, 2012 · Recall initiated: June 1, 2012
Summary
FDA records medical device Class II recall Z-0255-2013, published November 14, 2012 and initiated June 1, 2012. Recalling firm: Sysmex America, Inc.; Status: Terminated; Reported quantity: 763 units; Lot: catalog #063-7591-7, all serial numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sysmex America, Inc.
- Distributor
- Nationwide distribution: USA including Puerto Rico.
- Lot
- catalog #063-7591-7, all serial numbers
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe CF-70 instrument (product code: LXG; Regulation Number: 862.2050) receives magazines containing stainedApril 22, 2020
- FDASysmex CV-11 Sample Unit, an integrated modular sampler that conveys specimens to either the UF-5000 or UD-10April 22, 2020
- FDAThe UF-1000i is a fully automated urine particle analyzer intended for vitro diagnostic use in urinalysis. TheFebruary 19, 2014
- FDASysmex XE-2100C Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe,November 14, 2012
- FDASysmex XE-2100 Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe,November 14, 2012
- FDASiemens Dimension Vista(R) Homocysteine Flex(R) Reagent Cartridge This is an in vitro diagnostic test for theNovember 14, 2012
Questions about this recall
Was Sysmex XE-5000 Automated Hematology System; an automated differential cell counter; Sysmex Corporation, Kobe, Japan; Sysmex America, One Nelson C. White Parkway, Mundelein, IL 60060; catalog #063-7591-7 The Sysmex XE-5000 is an automated hematology analyzer for in vitro diagnostic use in screening patient populations found in clinical laboratories. The XE-5000 performs analyses using the following methods: RF/DC Detection Method, Sheath Row DC Detection Method, and Flow Cytometry Methods using a Semiconductor Laser. Particle characterization and identification is based on detection of forward scatter, fluorescence and adaptive cluster analysis. Using the same reagents as the XE-2100, the XE-5000 automatically classifies cells from blood and body fluids and carries out all processes automatically from aspiration of the sample to outputting the results. recalled?
Yes. FDA published recall Z-0255-2013 on November 14, 2012. Reported hazard: There is a variation of reticulocyte counts between XE Series (XE-2100, XE-5000) and XT-Series (XT-2000i, XT-4000i) hematology analyzers that may result in a retic counts that are an average of 21% lower on the XE-Series because of a low bias.
What should I do if I have this product?
Voluntary: Firm initiated · Letter